Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

• Hauptverfasser: Jose Navarro-Partida (Verfasst von), Juan Carlos Altamirano-Vallejo (Verfasst von), Luis Abraham Aceves Franco (Verfasst von), Jesús Gonzalez-Cortes (Verfasst von), Sergio Hernandez-Da Mota (Verfasst von), Jose Gerardo García-Aguirre (Verfasst von), Carlos David Azuara-Galindo (Verfasst von), Carlos Rodrigo Castro-Castaneda (Verfasst von), Juan Armendariz-Borunda (Verfasst von), Arturo Santos (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2021-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Novel strategies have been developed to reduce or avoid intravitreal injections (IVTs) of the antiangiogenic (ranibizumab (RBZ)) and anti-inflammatory (triamcinolone acetonide (TA)) agents used to treat vitreoretinal diseases. One of the strategies includes liposomes. This study evaluated the safety...